{
  "zip": "H9H 4R9",
  "sector": "Healthcare",
  "fullTimeEmployees": 27,
  "longBusinessSummary": "Valeo Pharma Inc. acquires and markets specialty products in the United States and Canada. Its product portfolio includes Synacthen, a neurology therapeutic for the treatment of severe multiple sclerosis and gout; and M-Eslon, an extended release morphine sulphate used for pain management. The company also offers Ondansetron ODT for prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used for the treatment of Parkinson's disease; and Onstryv, a safinamide tablet used to treat idiopathic Parkinson's disease. In addition, it develops Ethacrynate Sodium, a loop diuretic used to treat high blood pressure, as well as the swelling caused by diseases, such as congestive heart failure, liver failure, and kidney failure. The company was founded in 2003 and is headquartered in Kirkland, Canada.",
  "city": "Kirkland",
  "phone": "514 694 0150",
  "state": "QC",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.valeopharma.com",
  "maxAge": 1,
  "address1": "16667 Hymus Boulevard",
  "fax": "514 694 0865",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "previousClose": 1.1,
  "regularMarketOpen": 1.13,
  "twoHundredDayAverage": null,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 1.1,
  "navPrice": null,
  "averageDailyVolume10Day": null,
  "totalAssets": null,
  "regularMarketPreviousClose": 1.1,
  "fiftyDayAverage": null,
  "trailingAnnualDividendRate": null,
  "open": 1.13,
  "averageVolume10days": null,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 1.1,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 13000,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 65650972,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": null,
  "priceToSalesTrailing12Months": null,
  "dayLow": 1.1,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 13000,
  "fiftyTwoWeekHigh": 1.1,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.1,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 1.1,
  "exchange": "PNK",
  "shortName": "VALEO PHARMA INC",
  "longName": "Valeo Pharma Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "VPHIF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_36312531",
  "uuid": "1615232d-907d-3f97-ab33-1b4bff3432dc",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": -0.76486,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 0,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1572480000,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.53472,
  "nextFiscalYearEnd": 1635638400,
  "mostRecentQuarter": 1596153600,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 18580981,
  "enterpriseValue": 63878108,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 1.13,
  "logo_url": "https://logo.clearbit.com/valeopharma.com"
}